Form D · Private Equity Fund

270 Life Sciences Private Capital Fund I LP

New York, NY · CIK 0001959298

Offering snapshot reported Sep 5, 2023 · SEC filing

Reported sold
Yet to sell
Indefinite offering
Investors reported
0
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Yet to occur
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Sep 5, 2023InitialYet to sellNo comparison0SEC filing

Offering details

Securities
Equity, Pooled investment fund
Exemptions
06b, 3C, 3C.1, 3C.7
Duration over one year
No
Business combination
No
Sales commissions
$0 (estimated)
Finders' fees
$0 (estimated)
Form D file number
021-491365
The general partner of the Issuer reserves the right to offer a greater or lesser amount of limited partner interests. Total Offering Amount and Total Remaining to be Sold are aggregated with 270 Life Sciences Private Capital Fund I (Lux) SCSp-RAIF.

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
J.P. Morgan Institutional Investments Inc.102920
JPMorgan Asset Management (UK) Limited135960
JPMorgan Asset Management (Japan) LimitedNone
JPMorgan Asset Management (Europe) S.a r.l.304190

Source: Form D, filed Sep 5, 2023. Minimum accepted may differ from a standard advertised minimum.

Fund connections

The linked fund shows its most recently reported ADV details.

Matched by reported Form D file number

270 LIFE SCIENCES PRIVATE CAPITAL FUND I LP

Investment adviser: J.P. MORGAN INVESTMENT MANAGEMENT INC.

Gross asset value
$222M
Beneficial owners
120
ADV minimum commitment
$100K

Reported in Form ADV on Aug 26, 2026. Fund assets and beneficial owners measure different things from Form D sales and investors.

Service providers

Fund administrator CITCO JERSEY CITY, New Jersey, United States Investor statements: Yes (provided to all investors) Related to adviser: No
Auditor PRICEWATERHOUSECOOPERS LLP NEW YORK, New York, United States
Marketer J.P. MORGAN INSTITUTIONAL INVESTMENTS INC. NEW YORK, New York, United States Related to adviser: Yes
Marketer J.P. MORGAN SECURITIES LLC NEW YORK, New York, United States Related to adviser: Yes
Provider details
Annual audit
Yes
Prime brokers
No
Custodians
No
Administrator other than the adviser
Yes
External marketing
Yes

PRICEWATERHOUSECOOPERS LLP
PCAOB 238

J.P. MORGAN INSTITUTIONAL INVESTMENTS INC.
CRD 102920 · SEC 8-52182

J.P. MORGAN SECURITIES LLC
CRD 79 · SEC 801-3702

Filing source

Form ADV 2126828 · Aug 26, 2026 · Schedule D 7.B.(1), fund 805-8480200716

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Samantha Beattie Executive
Gaurav Gupta Executive
Patrick Mc Goldrick Executive
Anya Schiess Executive
Evan Sotiriou Executive
Stephen Squinto Executive

Issuer details

Industry: Pooled Investment Fund (See others in industry)

Address:
277 Park Avenue, Floor 23
New York, NY, 10017